ETHYL CERVONATE Trademark

Trademark Overview

On Wednesday, July 20, 2016, a trademark application was filed for ETHYL CERVONATE with the United States Patent and Trademark Office. The USPTO has given the ETHYL CERVONATE trademark a serial number of 87110717. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 2, 2018. This trademark is owned by Sancilio & Company, Inc.. The ETHYL CERVONATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders
ethyl cervonate

General Information

Serial Number87110717
Word MarkETHYL CERVONATE
Filing DateWednesday, July 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 2, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Disclaimer with Predetermined Text"ETHYL"
Goods and ServicesPharmaceutical preparations for the treatment and prevention of sickle cell disease, short bowel syndrome, hypertriglyceridemia, and inflammatory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSancilio & Company, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRiviera Beach, FL 33404
Party NameSancilio & Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRiviera Beach, FL 33404

Trademark Events

Event DateEvent Description
Monday, July 2, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 2, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2017EXTENSION 1 GRANTED
Thursday, November 30, 2017EXTENSION 1 FILED
Thursday, November 30, 2017TEAS EXTENSION RECEIVED
Thursday, November 30, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 30, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 23, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 23, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, February 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 10, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 7, 2016NON-FINAL ACTION E-MAILED
Monday, November 7, 2016NON-FINAL ACTION WRITTEN
Monday, October 31, 2016ASSIGNED TO EXAMINER
Tuesday, July 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 23, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

cervonate ethyl syndrome bowel hypertriglyceridemia inflammatory disorders short disease treatment preparations prevention